Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of “Moderate Buy” by Analysts

Shares of Haleon PLC Sponsored ADR (NYSE:HLN) have been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $12.3250.

Several analysts recently issued reports on the company. Morgan Stanley reissued an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft lowered Haleon from a “hold” rating to a “sell” rating in a research report on Monday, January 12th. Jefferies Financial Group restated a “buy” rating on shares of Haleon in a report on Tuesday, January 20th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a report on Thursday, January 22nd. Finally, HSBC raised shares of Haleon from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 21st.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in HLN. Norges Bank bought a new position in shares of Haleon in the 4th quarter worth about $163,529,000. Natixis Advisors LLC lifted its holdings in shares of Haleon by 429.8% during the fourth quarter. Natixis Advisors LLC now owns 10,003,941 shares of the company’s stock valued at $101,140,000 after purchasing an additional 8,115,633 shares during the last quarter. Bank of Montreal Can grew its stake in shares of Haleon by 454.1% in the 4th quarter. Bank of Montreal Can now owns 8,500,496 shares of the company’s stock worth $85,940,000 after buying an additional 6,966,416 shares during the last quarter. Bank of America Corp DE grew its stake in shares of Haleon by 116.7% in the 2nd quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock worth $128,423,000 after buying an additional 6,669,923 shares during the last quarter. Finally, Acadian Asset Management LLC increased its position in Haleon by 3,031.5% during the 2nd quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock valued at $55,813,000 after buying an additional 5,212,711 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

NYSE HLN opened at $11.20 on Friday. The company has a market capitalization of $49.85 billion, a P/E ratio of 28.71 and a beta of 0.19. Haleon has a 12-month low of $8.71 and a 12-month high of $11.42. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. The firm has a 50-day moving average price of $10.18 and a two-hundred day moving average price of $9.71.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.